Ulf Hellman
12Patents
7h-index
28Co-inventors
62Inventor score
Filing activity: Feb 27, 1990 → Jul 27, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5326695A | Platelet derived growth factor agonists | Human Necessities | 58 | Expired |
| US5229495A | Substantially pure receptor like TGF-.beta. 1 binding molecules and uses thereof | Human Necessities | 48 | Expired |
| US5578703A | Substantially pure receptor like TFG-.beta.1 binding molecules | Human Necessities | 14 | Expired |
| US5731200A | Isolated nucleic acid encoding receptor-like TGF-.beta.1 binding protein | Human Necessities | 13 | Expired |
| US5227302A | DNA encoding platelet derived endothelial cell growth factor (PD-ECGF) | Human Necessities | 9 | Expired |
| US5756686A | Peptides derived from endothelial cell growth factor | Chemistry; Metallurgy | 8 | Expired |
| US5177197A | Isolated nucleotide sequence expressing human transforming growth factor-.beta.1-binding protein | Chemistry; Metallurgy | 7 | Expired |
| US5444151A | Platelet derived growth factor antagonists | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5731195A | Isolated nucleic acid molecule which codes for a 32 kDa protein having 11-cis retinol dehydrogenase activity, and which associates with p63, a portion of a retinol binding protein receptor | Chemistry; Metallurgy | 4 | Expired |
| US6475775B1 | PARG, a GTPase activating protein which interacts with PTPL1 | Human Necessities | 0 | Expired |
| US8187889B2 | Protein markers for the diagnosis and prognosis of ovarian and breast cancer | Physics | 0 | Active |
| US6083721A | Isolated nucleic acid molecules encoding PARG, a GTPase activating protein which interacts with PTPL1 | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.